These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6638033)

  • 21. Stability and compatibility studies of cefaloridine, cefuroxime and ceftazidime with PVC infusion bags.
    Faouzi MA; Dine T; Luyckx M; Gressier B; Brunet C; Goudaliez F; Mallevais ML; Cazin M; Cazin JC
    Pharmazie; 1994 Jun; 49(6):425-7. PubMed ID: 8047543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cimetidine hydrochloride compatibility. III: Room temperature stability in drug admixtures.
    Yuhas EM; Lofton FT; Rosenberg HA; Mayron D; Baldinus JG
    Am J Hosp Pharm; 1981 Dec; 38(12):1919-22. PubMed ID: 7325173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets.
    Allen LV; Levinson RS; Phisutsinthop D
    Am J Hosp Pharm; 1977 Sep; 34(9):939-43. PubMed ID: 20779
    [No Abstract]   [Full Text] [Related]  

  • 24. Compatibility and stability of clindamycin phosphate with intravenous fluids.
    Porter WR; Johnson CA; Cohon MS; Gillespie W
    Am J Hosp Pharm; 1983 Jan; 40(1):91-4. PubMed ID: 6823996
    [No Abstract]   [Full Text] [Related]  

  • 25. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
    Trissel LA; Tramonte SM; Grilley BJ
    Am J Hosp Pharm; 1991 May; 48(5):988-92. PubMed ID: 1830190
    [No Abstract]   [Full Text] [Related]  

  • 26. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of cefamandole nafate injection with parenteral solutions and additives.
    Frable RA; Klink PR; Engel GL; Mundell EE
    Am J Hosp Pharm; 1982 Apr; 39(4):622-7. PubMed ID: 7082453
    [No Abstract]   [Full Text] [Related]  

  • 28. Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions.
    Lee YC; Baaske DM; Amann AH; Carter JE; Mooers MA; Wagenknecht DM; Lai CM
    Am J Hosp Pharm; 1980 Jun; 37(6):803-8. PubMed ID: 7395875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A stability and compatibility evaluation of a novel calcium entry blocker in admixture preparations.
    Kishnani NS; Visor GC
    J Parenter Sci Technol; 1988; 42(2):68-71. PubMed ID: 3385545
    [No Abstract]   [Full Text] [Related]  

  • 30. Compatibility of propranolol hydrochloride injection with intravenous infusion fluids in plastic containers.
    Cummings DS; Park MK; Howard AB
    Am J Hosp Pharm; 1982 Oct; 39(10):1685-7. PubMed ID: 7148843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compatibility of glycopyrrolate injection with commonly used infusion solutions and additives.
    Ingallinera TS; Kapadia AJ; Hagman D; Klioze O
    Am J Hosp Pharm; 1979 Apr; 36(4):508-10. PubMed ID: 433937
    [No Abstract]   [Full Text] [Related]  

  • 32. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32 degrees C.
    Xu Q; Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Dec; 51(24):3058-60. PubMed ID: 7856626
    [No Abstract]   [Full Text] [Related]  

  • 34. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Part 2.
    Allen LV; Stiles ML
    Am J Hosp Pharm; 1981 Mar; 38(3):380-1. PubMed ID: 7223755
    [No Abstract]   [Full Text] [Related]  

  • 35. Stability of midazolam hydrochloride in parenteral nutrient solutions.
    Bhatt-Mehta V; Rosen DA; King RS; Maksym CJ
    Am J Hosp Pharm; 1993 Feb; 50(2):285-8. PubMed ID: 8480785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical compatibility and chemical stability of cephapirin sodium in combination with non-antibiotic drugs in large-volume parenteral solutions. II.
    Prasad VK; Granatek AP; Mihotic MM
    Curr Ther Res Clin Exp; 1974 May; 16(0):540-72. PubMed ID: 4209520
    [No Abstract]   [Full Text] [Related]  

  • 37. Compatibility of netilmicin sulfate injection with commonly used intravenous injections and additives.
    Chaudry IA; Bruey KP; Hurlburt LE; Oden EM
    Am J Hosp Pharm; 1981 Nov; 38(11):1737-42. PubMed ID: 7304628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compatibility of verapamil hydrochloride with other additives.
    Cutie MR
    Am J Hosp Pharm; 1981 Feb; 38(2):231. PubMed ID: 7211888
    [No Abstract]   [Full Text] [Related]  

  • 39. Stability of ranitidine hydrochloride and seven medications.
    Stewart JT; Warren FW; King AD
    Am J Hosp Pharm; 1994 Jul; 51(14):1802-7. PubMed ID: 7942910
    [No Abstract]   [Full Text] [Related]  

  • 40. Compatibility of verapamil hydrochloride injection with commonly used additives.
    Cutie MR
    Am J Hosp Pharm; 1983 Jul; 40(7):1205-7. PubMed ID: 6881161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.